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Background and Purpose: Incidence of cardiovascular disorders increases with age,
because of a dramatic fall of endogenous self-defense mechanisms and increased
vulnerability of myocardium. Conversely, the effectiveness of many cardioprotective
drugs is blunted in hearts of 1 year old rat. The Citrus flavanone naringenin (NAR) was
reported to promote cardioprotective effects against ischemia/reperfusion (I/R) injury,
through the activation of mitochondrial large conductance calcium-activated potassium
channel (mitoBK). These effects were observed in young adult rats, but no data are
available about the possible cardioprotective effects of NAR in aged animals.
Experimental Approach: This study aimed at evaluating the potential cardioprotective
effects of NAR against I/R damage in 1 year old rats, and the possible involvement of
mitoBK.
Key Results: Naringenin protected the hearts of 1 year old rats in both ex vivo and
in vivo I/R protocols. Noteworthy, these effects were antagonized by paxilline, a selective
BK-blocker. The cardioprotective effects of NAR were also observed in senescent H9c2
cardiomyoblasts. In isolated mitochondria from hearts of 1 year old, NAR exhibited the
typical profile of a mitoBK opener. Finally, Western Blot analysis confirmed a significant
(albeit reduced) presence of BK-forming alpha and beta subunits, both in cardiac tissue
of 1 year old rats and in senescent H9c2 cells.
Conclusion and Implications: This is the first work reporting cardioprotective effects
of NAR in 1 year old rats. Although further studies are needed to better understand the
whole pathway involved in the NAR-mediated cardioprotection, these preliminary data
represent a promising perspective for a rational nutraceutical use of NAR in aging.
Keywords: naringenin, mitochondrial potassium channels, ischemia/reperfusion injury, cardioprotection,
flavonoids, nutraceutics
Abbreviations: Ai, infarct area; ALV, left ventricle area; DIAZO, diazoxide; DMEM, Dulbecco’s modified Eagle’s medium;
DMSO, dimethylsulfoxide; Dox, Doxorubicin; dP/dt, the rate of rise of the left ventricular pressure; ECG, electrocardiogram;
FBS, fetal bovine serum; HR, heart rate; IM, incubation medium; IPC, ischemic pre-conditioning; I/R, ischemia/reperfusion;
LAD, left anterior descending coronary artery; LVDP, left ventricular developed pressure; MI, myocardial infarct; mitoBK,
mitochondrial large conductance calcium-activated potassium channel; mitoKATP, mitochondrial ATP-sensitive potassium
channels; MPTP, mitochondrial permeability transition pore; NAR, Naringenin; PAX, paxilline; PE50, polypropylene tube;
RPP, rate pressure product; TPP+Cl−, tetraphenylphosphonium chloride; TTC, 2,3,5-triphenyltetrazolium chloride; 9m,
mitochondrial membrane potential.
Frontiers in Pharmacology | www.frontiersin.org 1 February 2017 | Volume 8 | Article 71
fphar-08-00071 February 23, 2017 Time: 13:43 # 2
Testai et al. Naringenin Produces Cardioprotection in Aging
INTRODUCTION
Incidence and prevalence of cardiovascular diseases, such as
coronary artery disease, hypertension and acute MI, increase
proportionally with age; moreover there is a strong correlation
between mortality due to MI and age. Indeed, it has been
observed that aging reduces cardiac tolerance against the
ischemic insult both in human and in animals (Lee et al.,
2002; Jahangir et al., 2007; Roger et al., 2011; Wojtovich
et al., 2012). In aged myocardium, endogenous self-defense
mechanisms, such as “ischemic pre-conditioning” (IPC), are
less effective and, consistently, the vulnerability of the heart is
increased (Boengler et al., 2009). The number of elderly people
is growing and in 2020 at least one-fifth of the population
is predicted to be composed of over 65 individuals; therefore
the understanding of the mechanisms which regulate cardiac
senescence and the development of effective pharmacological
strategies for myocardial protection is an urgent issue.
The fundamental processes that lead to cardiac aging
and loss of myocardial resistance are not yet completely
understood. Mitochondrial dysfunction in electron transport
or in oxidative phosphorylation is closely implicated in
the increased susceptibility to ischemic injury. These defects
witnessed by partial depolarization of membrane potential of
aged mitochondria and higher probability of MPTP opening
(Navarro and Boveris, 2007).
The activation of mitoKATP is a pivotal step in the
endogenous mechanisms of cardioprotection against I/R (Testai
et al., 2015). In aging, such mitoKATP-mediated cardioprotective
effects are compromised (Liu et al., 2011), but it is still unclear
whether this is due to changes in channel density, decreased
responsiveness to activating stimuli or defective respiratory chain
(Tricarico and Camerino, 1994; Tani et al., 2001).
Recent data of ours (Testai et al., 2013a,b) suggested that
NAR, a flavanone abundant in the Citrus genus, besides
already known vasoactive properties (Calderone et al., 2004;
Saponara et al., 2006), is able to promote cardioprotective
effects in young-adult rats (3–4 months old). These effects
may be due, at least in part, to anti-oxidant properties
typical of flavonoids; however, specific effects of flavonoids
on mitochondria- such as potassium influx, decreased calcium
uptake into the matrix, and a mild mitochondrial membrane
depolarization – may play a relevant role. These effects are likely
to be due to mitoBK activation (Testai et al., 2013b, 2015; Testai,
2015).
This study aimed at evaluating, in 1 year old rats, the potential
cardioprotective effects of NAR against I/R damage, and the
possible involvement of mitoBK in its mechanism of action.
MATERIALS AND METHODS
Substances
Naringenin was purchased from Sigma–Aldrich (CAS Number
67604-48-2, >95% of purity). The flavonoid was dissolved
(10−2 M) in DMSO, and further diluted in bi-distilled water. PAX
and valinomycin were purchased from Sigma–Aldrich (Milano,
Italy), dissolved in DMSO (10−2 M) and further diluted in bi-
distilled water. TPP+Cl− (Sigma–Aldrich, Milano, Italy) was
dissolved in bi-distilled water and TTC (Sigma–Aldrich. Milano,
Italy) was dissolved (1%, p/w) in phosphate buffer (pH 7.4).
Pharmacological Procedures
All the experimental procedures were carried out following
the guidelines of the European Community Council Directive
2010/63 and have been approved by the Animal Care Committee
of the University of Pisa, Italy (Protocol. N. 37321, October 22nd,
2013).
Langendorff-Perfused Rat Hearts
One year old male Wistar rats (400–500 g) were treated
intraperitoneally with NAR (100 mg/kg) or DIAZO, (40mg/Kg)
or their vehicle (DMSO). After 2 h, all the animals were
anesthetized with sodium pentobarbital (100 mg/kg i.p.) and
heparinized (100 UI i.p.); hearts were quickly excised and
mounted on a Langendorff apparatus, as previously described by
Calderone et al. (2010) and Testai et al. (2013a).
Heart rate, LVDP, and dP/dt were continuously monitored
by a computerized Biopac system Inc. (Goleta, CA,
USA). The functional parameter of RPP was calculated as
RPP = HR× LVDP. After 30 min of equilibration (pre-ischemic
period), the hearts were subjected to 30 min of global ischemia
(no flow). At the end of the ischemic period the hearts were
re-perfused for a period of 120 min. At the end of the reperfusion
period, left ventricle was cut in 2 mm large slices which were
immersed in a 1% aqueous solution of TTC for 20 min and
then in a 10% aqueous solution of formaldehyde. After 24 h, the
ventricular slices were photographed and analyzed in order to
highlight the necrotic areas due to the ischemic process (visible
as a white or light pink color and areas) and the healthy areas
(visible as strong red areas due to the TTC reaction).
Data analysis
In order to evaluate the cardiac inotropism in the reperfusion
phase, the LVDP recorded in the reperfusion time was calculated
and expressed as a percentage of the pre-ischemic value, recorded
at the last minute of perfusion. Furthermore, the ischemic areas
were evaluated planimetrically and expressed as a percentage
of the whole area of the slices of the left ventricle (Ai/ALV).
All the values are expressed as a mean ± standard error for
6–8 different experiments. Data were statistically analyzed by
ANOVA and P-values lower than 0.05 were considered as
indicative of significant differences.
In vivo Myocardial Acute Infarct
Two hours before the experimental procedures, 1 year old rats
(400–500 g) received an i.p. injection (about 0.5 ml) of NAR
(100 mg/kg) or vehicle (DMSO).
Then, rats were anesthetized with sodium pentobarbital
(70 mg/kg, i.p.) and the experimental protocol for coronary
occlusion-reperfusion was performed as described in Calderone
et al. (2010) and Testai et al. (2013b).
The acute infarct protocol consisted of 30 min
occlusion/120 min reperfusion; successful occlusion was
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confirmed by observing regional cyanosis downstream of
the ligature, and by ST elevation in the ECG recording.
In another experimental group, the selective BK-blocker
PAX was administered (10 mg/kg i.p.) 10 min before the
administration of NAR. A group of vehicle-pretreated animals
was submitted to an IPC procedure, achieved by two cycles
of 5 min occlusion/10 min reperfusion, followed by 30 min
coronary occlusion and 120 min reperfusion. At the end of
reperfusion, rats were euthanized by an overdose of sodium
pentobarbital, then hearts were quickly excised, mounted on
a Langendorff apparatus (Radnoti, Monrovia, CA, USA) and
perfused for 10 min with Krebs solution at 37◦C to wash out the
coronary blood vessels. Then, left ventricular tissue was dried,
frozen at −20◦C, and cut into 4–5 transverse slices from the
apex to the base of equal thickness (about 2 mm). The slices were
then incubated in a TTC solution in a phosphate buffer (pH
7.4) at 37◦C for 20 min. TTC reacts with NADH in the presence
of dehydrogenase enzymes, to form a formazan derivative,
which stain the viable cells with intense red color. Then, the
slices were fixed overnight in 10% formaldehyde and finally
they were photographed. In the viable area, red-stained viable
tissue was easily distinguished from the white-unstained necrotic
tissue.
Data analysis
The Ai was planimetrically evaluated using an image analyzer
program (The GIMP 2). The infarct size was calculated as a
percentage of the whole left ventricle area (Ai/ALV).
All the values are expressed as a mean ± standard error
for 6–8 different experiments. Data were statistically analyzed
by ANOVA and P-values lower than 0.05 were considered as
indicative of significant differences.
Isolated Cardiac Mitochondria
Isolation procedure
Rat cardiac mitochondria were isolated by differential
centrifugation, as previously described (Calderone et al.,
2010; Testai et al., 2013b, 2016), with minor modifications. 1 year
old male Wistar rats (400–500 g) were killed by pentobarbital
overdose, hearts were removed immediately and placed in an ice
cold isolation buffer (IB1, composition mM: sucrose 250, Tris 5,
EGTA 1, pH 7.4 adjusted with HCl). The atria were removed and
the ventricular tissue was finely minced with surgical scissors
(about 2 mm3pieces) and homogenized using an Ultra-Turrax
homogenizer (20 ml of isolation buffer per heart, IKA1-Werke
GmbH & Co., Staufen, Germany).
Three homogenization cycles (each of 20 s) were performed
on ice, and then the suspension was centrifuged at 1075 g
for 3 min at 4◦C (EuroClone, Speed Master 14 R centrifuge,
Milano, Italy). The resulting supernatant was centrifuged at
11950 g for 10 min at 4◦C. The pellet containing the
mitochondrial fraction was further re-suspended in the isolation
buffer (without EGTA, IB2) and centrifuged at 11950 g for
10 min at 4◦C, this step was repeated once more. The final
mitochondrial pellet was re-suspended in a minimal volume
of 400 µl of the IB2 and stored on ice throughout the
experiments, which were performed within 2 h. Mitochondrial
protein concentrations were determined using the usual Bradford
reaction.
Mitochondrial membrane potential
Mitochondrial membrane potential (9m) was potentiometrically
measured with tetraphenylphosphonium (TPP+)-sensitive mini-
electrodes, coupled with a reference electrode (WPI, FL, USA),
using a data acquisition software (Biopac Systems Inc., Goleta,
CA, USA), as previously described (Calderone et al., 2010).
Briefly, electrodes were calibrated before each experiment
using known concentrations of TPP+Cl−. Mitochondria (1 mg
protein/ml) were suspended under gently stirring in the IM,
(composition mM: KCl 120, K2HPO4 5, Hepes 10, succinic acid
10, MgCl2 2, EGTA 1, plusTPP+Cl−10 µM, pH 7.4 adjusted
with KOH). The potential value was calculated by a Nernst-
derived experimental equation as published by Lábajová et al.
(2006). Changes of 9m were continuously recorded (in mV)
before and after the addition in the IM of cumulative increasing
concentrations of NAR (10–100 µM). When required, PAX
(10 µM), a blocker of BK channels, was incubated in the medium
2 min before the mitochondria addition. Moreover, the effects of
the addition of the corresponding vehicle were evaluated.
Data analysis. The effects of NAR on the mitochondrial
membrane potential were expressed as changes (in mV) from
the basal levels. All data were expressed as a mean ± standard
error. Each concentration-response curve was obtained with
mitochondria isolated from the hearts of 6–10 different animals.
Data were statistically analyzed by ANOVA and Student’s t-test
(software: GraphPad Prism 5.0). P-values lower than 0.05 were
considered as indicative of significant differences.
Mitochondrial calcium-uptake
Mitochondrial calcium-uptake was measured by potentiometric
technique, as previously described (Calderone et al., 2010). In
particular, the changes of the calcium concentration in the
medium (i.e., extra-mitochondrial calcium) were continuously
measured with a calcium-selective mini-electrode, coupled with
a reference electrode (WPI, FL, USA), using a data acquisition
software (Biopac Systems Inc., Goleta, CA, USA). In order to
correlate the potentiometric measurements (in mV) with the
corresponding concentrations of calcium ions in the solution,
calibration curves were generated before each experiment, by
using known concentrations of CaCl2. Mitochondria (1 mg
protein/ml) were added, under gently stirring, to the IM plus
CaCl2 100 µM in the presence of vehicle (DMSO 1%) or NAR
(100 µM). After the addition of mitochondria, the maximal
decrease of the calcium concentration in the medium, related to
its accumulation in the mitochondrial matrix, was measured.
Data analysis. Mitochondrial Ca2+–uptake was evaluated by
measuring the reduction of the extra-mitochondrial Ca2+
concentration, following the addiction of mitochondria into
calcium rich buffer. All data are expressed as a mean ± standard
error. Data were statistically analyzed by ANOVA and Student’s
t-test (software: GraphPad Prism 4.0). P-values lower than 0.05
were considered as indicative of significant differences. Each
result was obtained with mitochondria isolated from the hearts
of 3–6 different animals.
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Activation of mitochondrial potassium channels
The potential NAR-induced activation of mitochondrial
potassium channels was carried out with a novel fluorimetric
approach, based on the potassium-mimetic behavior exhibited
by thallium ions (Tl+) and the use of a specific Tl+-sensitive
fluorescent probe (benzothiazole coumarin acetoxymethyl
ester), available in a commercial kit (FluxOR, Invitrogen,
Monza, Italy). Such an approach, originally used to study
sarcolemmal potassium channels, has been set up to evaluate
the modulation of potassium channels on isolated mitochondria
(Testai et al., 2013b). After the above isolation procedures,
mitochondria were incubated with loading buffer (containing
the Tl+-sensitive probe) for 10 min at room temperature under
continuous stirring in the dark, in order to allow the Tl+-
sensitive probe to accumulate into the mitochondrial matrix.
Then, the mitochondria were diluted with IB2 and centrifuged
at 11,950 g for 10 min at 4◦C, this step was repeated twice,
in order to remove the residual Tl+-sensitive probe from the
extramitochondrial medium. The final pellet was re-suspended
in a minimal volume (400 µl) of IB2 and stored on ice until use.
Mitochondrial proteins were determined via Bradford method.
Immediately before the test, the stored mitochondrial
suspension was further diluted (0.5 mg mitochondrial
protein/ml) in mannitol buffer (composition: mannitol 240 mM,
Na2HPO4 5 mM, Hepes 10 mM, succinic acid 10 mM, MgSO4
2 mM, ATP 200 µM, pH 7.4). Then, into a black 96-multiwell
plate (80 µl/well) suitable for the fluorescence assay, the
potassium ionophore valinomycin (2 µM, reference compound),
NAR (100 µM), or their corresponding vehicle (DMSO 1%) were
added in the wells and finally, after 2 min, aqueous solution of
Tl2SO4 (100 µM) was further added into each well.
Data analysis. The increase in fluorescence (due to the eventual
Tl+ entry into the matrix, through potassium channels) was
monitored (λex = 488 nm, λem = 525 nm) by the EnSpire
multiplate reader (PerkinElmer, Boston, MA, USA). These
experiments were completed within 1.5 h after the isolation
of mitochondria. Each result was obtained with mitochondria
isolated from the hearts of 3–6 different animals. All data were
expressed as a mean ± standard error. Data were statistically
analyzed by ANOVA and Student’s t-test (software: GraphPad
Prism 5.0). P-values lower than 0.05 were considered as indicative
of significant differences.
Cell Cultures
H9c2 subclonal cell line, deriving from embryonic rat hearts
(Hescheler et al., 1991) was purchased from ATTC (Manassas,
VA, USA). H9c2 cells were cultured, following the usual
procedures in DMEM, (Sigma–Aldrich, St. Louis, MO, USA)
supplemented with 10% FBS, (Sigma–Aldrich, St. Louis, MO,
USA), 100 units/ml penicillin and 100 mg/ml streptomycin in
tissue culture flasks at 37◦C in a humidified atmosphere of 5%
CO2.
H9c2 Cell Senescence model
Senescence in H9c2 cells was induced by Dox as previously
reported (Spallarossa et al., 2009). Briefly, cells were cultured up
to about 80% confluence in a DMEM medium and before the
experiments, cells were seeded onto 24-well plates at a density
of 10 × 103 cell/cm2. After 24 h to allow cell attachment, the
medium was replaced in each well and the cells received different
treatments such as vehicle (0.1% DMSO), various concentrations
of Dox (0.01, 0.05, and 0.1 µM) for 3 h, and were subsequently
cultured for 3 days, after which senescence was determined.
Senescence-associated β-galactosidase (sa-beta-Gal) staining. To
evaluate the number of senescent cells after 3 days from
Dox insult, the senescence marker sa-beta-Gal was detected
as previously reported (Costa et al., 2013). According to the
method described, treated cells were fixed in p-formaldehyde and
incubated in freshly prepared staining solution for 16 h at 37◦C
in a dry incubator. Cells were then washed in PBS (1×) and
photographed at 100× magnification. Images of random light
microscopic fields were captured (five fields per well), and both
blue and total cells were counted using ImageJ (ImageJ Software,
version 1.41; USA).
RNA extraction and Real Time PCR analysis. After 72 h Dox
treatment, injured H9c2 cells were collected, and total RNA was
extracted using RNeasy R© Mini Kit (Qiagen, Hilden, Germany)
according to the manufacturer’s instructions. cDNA synthesis was
performed with 500 ng of RNA using the i-Script cDNA synthesis
kit (Bio-Rad, Hercules, CA, USA) following the manufacturer’s
instructions. Real time RT-PCR reactions consisted of 25 µL
of Fluocycle R© II SYBR R© (Euroclone, Milan, Italy), 1.5 µL of
both 10 µM forward and reverse primers, 3 µL of cDNA, and
19 µL of H2O. All reactions were performed for 38 cycles
using the following temperature profiles: 94◦C for 1 min (initial
denaturation); 55–59◦C for 30 s (annealing); and 72◦C for 1 s
(extension).
Cell cycle analysis. The measurement of the percentage of Dox
injured cells in the different cell phases was performed using
the MuseTM Cell Analyser (Merck KGaA, Darmstadt, Germany).
Briefly, senescent adherent cells were collected and centrifuged at
300× g for 5 min. The pellet was washed with PBS and suspended
in 100 µl of PBS; finally, the cells were slowly added to 1 ml
of ice cold 70% ethanol and maintained over night at −20◦C.
Then, a cell suspension aliquot (containing at least 2 × 105 cells)
was centrifuged at 300 × g for 5 min, washed once with PBS
and suspended in the fluorescent reagent (MuseTM Cell Cycle
reagent) (Daniele et al., 2014).
Data analyses. The non-linear multipurpose curve-fitting
program Graph-Pad Prism (GraphPad Software Inc., San Diego,
CA, USA) was used for data analysis and graphic presentations.
All results are presented as the means ± standard errors of the
means (SEM) of data for duplicate samples and are representative
of three different experiments. Statistical analysis was performed
by one-way analysis of variance (ANOVA) with Bonferroni’s
corrected t-test for post hoc pair-wise comparisons, or by t-test.
P < 0.05 was considered statistically significant.
Cell viability on anoxia/reoxygenation (A/R) injury
To simulate anoxia in senescent H9c2 cells, plated cells
(3.5 × 103 cells/cm2) were exposed to a low-glucose and serum-
free solution, added with NAR (4–40 µM) in the presence or
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in the absence of PAX (10 µM), and sealed for 16 h in airtight
containers saturated with 95% N2 and 5% CO2 (37◦C), whereas
twin plates were placed in 95% air and 5% CO2 (normoxic
conditions), as previously reported (Calderone et al., 2010). Then,
cells were re-oxygenated for 2 h in normoxic conditions (37◦C).
After re-oxygenation, cell viability was assessed by quantitative
colorimetric MTS assay kit according to manufacturer (Cell Titer
96 R© AQueous one Solution Cell Proliferation assay, Promega).
After 2 h of incubation with the reagent, the absorbance of
individual wells was measured by microplate reader (Wallac
Victor 2, 1420 Multilabel counter, PerkinElmer). Each drug
concentration was tested in triplicate and the experiments were
repeated at least three times.
Western Blot Analysis
The mitochondrial pellet obtained from rat ventricles and H9c2
cells were resuspended in IB2. When mitochondrial pellet from
left ventricular tissue was used, rat hearts were obtained from
young (3–4 months old) and 1 year old animals. 100 µl of
mitochondrial suspension were incubated with 2.5 µl of Triton
X-100 20%, 10 µl KCl 2.5 M, 1 µl of protease inhibitor
cocktails and incubated at room temperature for 5 min. After
centrifugation (12.000 rpm for 5 min) the protein concentration
was determined by Bradford (Bio-Rad, Milan, Italy) method. The
samples were preserved by adding an equal volume of loading
buffer (1:1) (Sample Buffer, Sigma–Aldrich, Milan, Italy).
Fifty micrograms of mitochondrial proteins were loaded on
4–20% sodium dodecyl sulfate–polyacrylamide precast gel (cod.
4561095, Bio-Rad, Milan, Italy), separated by electrophoresis and
transferred to a polyvinylidene fluoride membrane by Semi-Dry
Electrophoretic transfer cell for 7 min a 12,5V (cod. 1703940, Bio-
Rad, Milan, Italy).
Unspecific binding of the antibody was blocked by incubation
with 3% fat-free milk solution in Tris-buffered saline containing
0.1% Tween for 1 h. Subsequently, the membrane was incubated
overnight at 4◦C with anti-MaxiKa or anti-Sloβ1 subunit
antibodies (1:1,000 and 1:200, respectively, AbCam, Cambridge,
UK). After washing (3× 10 min) in 3% fat-free milk solution, the
blot was subjected to the appropriate horseradish peroxidase –
conjugated secondary antibody for 2 h at room temperature.
Data analysis
Bands were visualized using a chemoluminescence kit (Millipore,
Milan, Italy) and quantified by optical densitometry. Images
were acquired using Image Quant LAS4010 (GE Healthcare,
Buckinghamshire, UK). On the same blots, protein contents
were normalized to the amounts of ATP5A (1:500, AbCam,
Cambridge, UK).
RESULTS
Effects on Isolated Heart Submitted to
I/R
Ischemia/reperfusion episode caused an evident myocardial
damage in isolated hearts of 1 year old rats. Indeed, when
compared with the corresponding pre-ischemic values,
functional parameters of RPP and dP/dt were about half-reduced
during the whole reperfusion period; moreover the histological
assay highlighted an extended damage area (Ai/ALV = 50 ± 6%)
which was significantly higher than that observed in the young
one (Ai/ALV 36± 7%) (Figures 1A–D).
In isolated hearts of 1 year old rats, DIAZO did not produce
cardioprotective effects and the post-ischemic functional and
histological parameters were almost identical to the control ones
(RPP value was superimposable with vehicle and Ai/ALV was
45± 1%) (Figures 1A–D).
Surprisingly, NAR was cardioprotective in hearts from 1 year
old rats submitted to I/R episode. Indeed, functional recovery
was significantly improved (RPP% 90 ± 16 at 120th min of
reperfusion) and it was quite stable for the whole reperfusion
period (Figure 1A). In agreement with the inotropic value,
ischemic area size was markedly reduced (Ai/ALV% = 31 ± 5)
(Figure 1D).
Effects of NAR in Acute Myocardial
Infarct
In vehicle-treated 1 year old animals, submitted to the
experimental protocol of acute infarct, large extension of I/R
injury could be detected (Ai/ALV = 38 ± 0.5%). IPC induced
no significant reduction of the I/R injury (Ai/ALV = 32 ± 4%),
whereas the pharmacological pretreatment with NAR led to a
significant reduction of the I/R injured areas (Ai/ALV= 15± 6%).
PAX completely abolished the cardioprotective effects of NAR
(Ai/AL = 47± 1%) (Figure 2).
Mitochondrial Effects of NAR
Cardiac mitochondria from 1 year old rats possess a membrane
potential slightly but significantly more depolarized if compared
with young ones, in agreement with literature (−159 ± 6 vs.
−174± 4 mV; Jahangir et al., 2001). The addition of cumulatively
increasing concentrations of NAR (10–100 µM) to a suspension
of cardiac mitochondria from 1 year old rats (1 mg/ml) caused
a concentration-dependent depolarization of the mitochondrial
membrane, with a maximum increase of 31± 4 mV caused by the
highest concentration of the flavonoid. Moreover, NAR-induced
effects were significantly antagonized by PAX 10µM (Figure 3A).
In contrast, DIAZO, administrated to cardiac mitochondrial
suspensions deriving from 1 year old rats, didn’t produce
significant effects on membrane potential (data not shown). The
addition of the potassium ionophore valinomycin (2 µM) to
isolated cardiac mitochondria allowed the potassium-mimetic
Tl+ ions to enter massively into the mitochondrial matrix. Such
an effect was witnessed by great increase of fluorescence of the
Tl+-sensitive probe previously accumulated into the matrix.
The administration of NAR 100 µM led to a significant
increase in fluorescence (41 ± 5% of the fluorescence triggered
by valinomycin), indicating a large Tl+ influx into the matrix
(Figure 3B).
Moreover, cardiac mitochondria derived from 1 year
old rats were able to accumulate calcium into the matrix
(51± 15µM). However, the calcium up-take in the mitochondria
of 1 year old hearts was about half reduced, when compared
Frontiers in Pharmacology | www.frontiersin.org 5 February 2017 | Volume 8 | Article 71
fphar-08-00071 February 23, 2017 Time: 13:43 # 6
Testai et al. Naringenin Produces Cardioprotection in Aging
FIGURE 1 | Post-ischemic functional parameters of RPP (A), CF (B), and dP/dt (C) recorded during the reperfusion time in Langendorff-perfused hearts of
1 year old rats pre-treated with vehicle, NAR 100 mg/kg or DIAZO 40 mg/kg. Two way ANOVA indicated that the curves obtained following NAR-treatment show
significant differences (P < 0.01) vs. vehicle. The corresponding data emerging from the morphometric analysis of the tissue injury are also shown; asterisks indicate
significant differences (∗P < 0.05) vs. vehicle (D).
with that observed in young ones (data not shown). As
expected, DIAZO 100 µM was ineffective in 1 year old
cardiac mitochondria (calcium up-take: 38 ± 18 µM).
In contrast, NAR significantly inhibited the calcium up-
take in 1 year old rat-derived mitochondria (8 ± 6 µM)
(Figure 3C).
Induction of H9c2 Cell Senescence
A concentration-dependent increase of sa-β-gal was observed
following the H9c2 cell treatment with increasing concentrations
of Dox (Figures 4A,B). These results allowed us to establish Dox
0.05 µM as the effective concentration for the following H9c2 cell
experiments.
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FIGURE 2 | Values of injured areas (expressed as % of the left ventricle
area Ai/ALV %) observed in the left ventricles isolated from 1 year old
rats treated with vehicle, NAR, NAR+PAX or submitted to
pre-conditioning ischemia (IPC) before the protocol of in vivo acute
infarct. The asterisks indicate a statistically significant difference from the
value observed in the hearts of vehicle treated animals (∗P < 0.05).
Moreover, the real time RT-PCR results showed that Dox cell
treatments significantly increased the p16 and p21 mRNA levels
in H9c2 cells (p < 0.01 and p < 0.001, Figure 4C). Consistent
with these results, cell cycle analysis evidenced arrest of cell cycle
progression in G2/M phase after Dox treatments (p < 0.01 and
p< 0.001, Figure 4D).
A/R Survival of H9c2 Cells
In normoxic conditions, Dox-mediated induction of cell
senescence was associated with a significant reduction in cell
viability, with respect to non-senescent control cells (about 60%,
P < 0.01). When senescent H9c2 cells were subjected to A/R a
further reduction of cell viability was recorded (40%, p < 0.001).
NAR (4 and 40 µM) evoked significant cytoprotective effects
against A/R injury, resulting in a significant improvement of
cell viability (about 60 and 55%, respectively); the BK-blocker
PAX 10 µM markedly antagonized the protective effects of NAR
(Figure 5).
Western Blot Detection of mitoBK in
Tissue and Cells
Western blot analysis, using α- and β1-subunit-specific
antibodies, was carried out in mitochondrial lysate from ventricle
tissue of young and 1 year old rats, as well as in “young” and
“aged” H9c2 cardiomyoblasts. It detected bands of 130 and
28 kDa, respectively (Figure 6). Immunoblots showed that both
α- and β1-subunit are present in mitochondria of young and
1 year old hearts, as well as in “young” and “aged” H9c2 cells.
However, protein expression dramatically decreased with aging,
in both the experimental models. The relative amount of α-
and β1-subunit of the BK channel (normalized to the ATP5A
signal in three different membranes) is shown in Figure 6A
for mitochondrial lysate obtained from rat ventricle, and in
Figure 6B for mitochondrial lysate obtained from H9c2 cell line.
DISCUSSION
During dramatic cell stress, such as I/R, mitochondria play
a crucial role in deciding the cell fate: apoptotic death or
survival. Mitochondria are very sensible to oxidative damage,
FIGURE 3 | (A) Concentration-dependent changes in mitochondrial membrane potential, induced by the cumulative administration of increasing concentrations of
NAR to isolated cardiac 1 year old mitochondria. Two-way ANOVA indicated statistically significant differences between the curve obtained in control condition and
those obtained in the presence of PAX (10 µM). (B) Increase of the fluorescence (expressed as a % of that induced by the potassium-ionophore valinomycin)
produced by a Tl+-sensitive probe accumulated into the mitochondrial matrix, after the addition of Tl+ ions to a suspension of isolated cardiac 1 year old
mitochondria in the presence of NAR (100 µM). The asterisks indicate a statistically significant difference (∗P < 0.05). (C) The reduction of the extra-mitochondrial
calcium concentration (in µM), following the administration of isolated cardiac mitochondria from 1 year old rats in the presence of NAR 100 µM, DIAZO 100 µM, or
their vehicle. The asterisks indicate a statistically significant difference (∗P < 0.05).
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FIGURE 4 | (A) Percentage of β-galactosidase positive cells observed after treatment with different increasing concentrations of Dox. (B) Representative phase
contrast photomicrographs of treated cells (control, Dox 0.05 µM and Dox 0.1 µM, respectively). (C) Real mRNA levels, indicative of an induction of p16 and p21
mRNA, and (D) cell cycle phases analyses. The asterisks indicate a statistically significant difference (∗∗∗p < 0.001, ∗∗p < 0.01 vs. control group).
FIGURE 5 | Cell viability of senescent H9c2 cells under hypoxic
conditions. Percentage of cell viability compared to the control
(non-senescent normoxic H9c2 cells) to which a viability of 100% was
attributed. The asterisks indicate a statistically significant difference vs. control
(∗∗∗p < 0.001); the hashtags indicate statistically significant difference vs. A/R
injury vehicle. (###p < 0.001, ##p < 0.01, #p < 0.05).
naturally associated with aging. Indeed, the oxidative stress
accounts for defective mitochondrial protein synthesis, alteration
in the mitochondrial respiratory chain and loss of mitochondrial
membrane potential, influencing the calcium homeostasis and
the mitochondrial bioenergetics (Wojtovich et al., 2012). In aged
hearts, both endogenous protective mechanisms such as IPC
and drugs mimicking IPC are ineffective. For instance, DIAZO
and other KATP-activators (effective cardioprotective drugs in
young hearts) are poorly effective in aged hearts (Tani et al.,
2001; Heinen et al., 2008a,b; Boengler et al., 2009). An exhaustive
explanation of this loss of efficacy is missing, although several
authors hypothesized that it can be due to channelopathies,
linked to defective expression/function of some types of mitoK
channel in aged myocardium (Tani et al., 2001; Pi et al., 2007).
In agreement with the literature (Jahangir et al., 2001), aged
cardiac mitochondria showed a more depolarized mitochondrial
membrane and a lower calcium upload. As expected, we observed
a higher vulnerability to I/R injury in elderly animals, likely to be
due to possible aging-dependent defects in expression/function
of mitoK channels, or with alterations in the signal transduction
downstream of mitoK channel activation in aged myocardium (Pi
et al., 2007).
As regards mitoBK channels, composed by at least two
kinds of (the pore-forming α subunit and a regulatory β1
subunit), data are conflicting (Wang et al., 2008; Singh et al.,
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FIGURE 6 | Reduction of α and β subunits of BK channel, indicated as maxiKa and slo-β1, respectively, in mitochondrial membranes. (A) Western blot
analysis of both α and β subunits in mitochondrial membranes obtained from young and old rat ventricle. Left panel shows a representative example of western blot
experiment. Right panel shows a significant reduction of protein expression in “old” ventricle (black bars) respect to “young” ventricle (white bars). (B) Western blot
analysis of both α and β subunits in mitochondrial membranes obtained from H9c2 cell line after treatment with Dox (“old” cell) or DMSO alone (“young” cell). Left
panel shows a representative example of western blot experiment. Right panel shows a significant reduction of protein expression in “old” H9c2 (black bar)
compared to the “young” H9c2 (white bars). Bars represent the mean ± SEM (n = 3 independent experiments). Statistic t-test ∗P < 0.05, ∗∗P < 0.01.
2013). Recently, it has been demonstrated that pharmacological
targeting of mitoBK channels with a well-known BK opener
(NS1619) can induce cardioprotection not only in the young
but also in the aged rat heart (Huhn et al., 2012). However,
NS1619 is reported as a non-selective agent, and a number of
further a specific actions have been demonstrated (Testai et al.,
2015). On the other hand, it has been observed that mitoBK-
dependent helium’s effects on reduction of infarct size in young
rats were lost in aged rats. Indeed, aging-related decrease in
density of BK β1 subunit expression may justify this loss of
cardioprotection, together with downregulation of signaling steps
underlying the PKA activation and connexin 43 (Heinen et al.,
2008b, 2014).
In this context, the main finding of this study is that NAR,
a flavanone abundant in the Citrus genus, is endowed with
cardioprotective activity, not only in young animals (Testai et al.,
2013b), but also in 1 year old ones. Indeed, NAR-treated 1 year old
rats showed a minor extension of myocardial damage both in ex
vivo and in in vivo I/R protocols. Noteworthy, cardioprotection
mediated by NAR failed when PAX was administered before the
NAR treatment, leading us to speculate that mitoBK channels
may be involved.
Such a hypothesis has been evaluated in mitochondria
isolated from hearts of 1 year old rats, where the flavonoid
produced typical effects of mitoK openers: mild depolarization
of mitochondrial membrane, reduced accumulation of calcium
ions into the matrix and influx of potassium-mimetic thallium
ions.
H9c2 cells represent a model of normal primary
cardiomyocytes regarding energy metabolism; they have been
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successfully used as a reliable in vitro model to simulate
cardiac ischemia–reperfusion injury (Calderone et al., 2010;
Kuznetsov et al., 2015) and to study myocardial pathophysiology
including aging processes (Spallarossa et al., 2009). Dox
treatment of H9c2 cells caused a clear expression of senescence
hallmarks: β-galactosidase positive staining, p16 and p21 mRNA
increase, cell cycle arrest, and DNA damage (Spallarossa et al.,
2009; Bernardes de Jesus and Blasco, 2012). In particular,
cell cycle analysis evidenced a cell cycle arrest in G2/M
phase, in accordance with previous studies (Vulliamy, 2009;
Lüpertz et al., 2010; Oyama et al., 2011; Gire and Dulic,
2015).
In agreement with data obtained in hearts of 1 year old
rats, NAR evoked cytoprotective effects even in senescent H9c2
submitted to A/R.
Western Blot analysis allowed us to evaluate the influence
of aging on expression of subunits forming mitoBK channel, in
heart tissue as well as in H9c2 cardiomyoblasts. In agreement
with results obtained in rat mesenteric artery (Shi et al., 2013),
mitoBK subunits α and β were reduced in expression, but were
still present in cardiac tissues of 1 year old rats as well as in
senescent H9c2 cells.
CONCLUSION
In aged hearts, a reduced effectiveness of well-known
cardioprotective drugs (for instance, the KATP-opener DIAZO)
has been observed. In this paper, we first report that NAR, a
flavonoid derivative, exhibits cardioprotective effects against
I/R injury, even in 1 year old animals. Furthermore, in this
paper we demonstrated also a possible correlation between
cardioprotection and activation of mitoBK channels, indicating
that mitoBK, albeit reduced in expression with aging, may
represent a reliable pharmacological target for cardioprotective
purposes.
Further studies are needed to better understand the whole
pathway involved in the cardioprotection afforded by NAR and
other BK activators, and to investigate the promising perspective
of a rational nutraceutical use of NAR, aimed to improve
mitochondrial function and/or slow down the mitochondrial
dysfunction in aging.
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